Grant ID PP170042
Awarded On February 15, 2017
Title University Health System Hepatitis Viral Infection and Systematic Treatment Program (HepVISTA)
Program Prevention
Award Mechanism Evidence-Based Prevention Programs and Services
Institution/Organization University Health System
Principal Investigator/Program Director Roberto Villarreal
Cancer Sites Gallbladder, Liver and Intrahepatic Bile Duct
Contracted Amount $1,238,838
Lay Summary

Need: South Texas has the highest incidence of Hepatocellular Carcinoma (HCC) in the United States, about 5% higher than the rest of the country. From 2011 to 2013, the liver cancer mortality rate for Hispanics in Bexar County (14.4 per 100,000) exceeded the rate for White (6.5) and African Americans (7.9).

The Hepatitis C virus (HCV) is the major risk for HCC, and the majority of Hepatitis C Virus (HCV) positive patients are baby boomers (i.e., those born 1945-1965). In previous studies, we demonstrated that University Health System baby boomers had more than twice the prevalence of HCV when compared to national estimates. The current HCV screening rate is 11% for this age group, highlighti...

Read More